@article{4b2add72f6be48acb9ff16d4e8c868bf,
title = "Letter: safety of immune checkpoint inhibitors in patients with pre-established microscopic colitis—a single-centre experience",
author = "Fredrick, {Thomas W.} and {Braga Neto}, {Manuel B.} and Ramos, {Guilherme P.} and Sunanda Kane and Pardi, {Darrell S.} and Raffals, {Laura E.}",
note = "Funding Information: Sunanda Kane has served as a consultant for Janssen, Bristol Myers Squibb, Spherix Health, United Healthcare, TechLab and is an Editor for UpToDate. Darrell S. Pardi has served as a consultant for Vedanta, Seres, and Otsuka. He has received research funding from Atlantic, Finch, Janssen, Pfizer, Seres, Takeda, Vedanta, and Applied Molecular Transport. Laura Raffals is an Editor for UpToDate. Author contributions :",
year = "2021",
month = jul,
doi = "10.1111/apt.16458",
language = "English (US)",
volume = "54",
pages = "217--218",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "2",
}